Medicine & Health

Nephrologist Benjamin Humphreys, MD, PhD, director of the Division of Nephrology at the School of Medicine, is a leading innovator in kidney research. Humphreys seeks to find better treatments to prevent kidney failure, a potentially fatal condition affecting 37 million Americans.

Jonathan Silva, a biomedical engineer in the McKelvey School of Engineering at Washington University in St. Louis, has developed the first computational model that shows the molecular groundwork of a popular drug’s effectiveness in a variety of ways.

Contrary to the belief that drinking can literally shrink one’s brain, a new study that includes researchers from Arts & Sciences suggests that a small brain might be a risk factor for heavier alcohol consumption.

Medical scientists at the Taylor Family Institute for Innovative Psychiatric Research have pioneered the use of neurosteroid drugs to treat psychiatric illness.

Mothers in low-income neighborhoods report more physical and social barriers that discourage them from allowing their children to play outside, according to new research from the Brown School at Washington University in St. Louis.

A human antibody that protects mice against a wide range of lethal flu viruses could be the key to a universal vaccine and better treatments for severe flu disease, according to a new study from Washington University School of Medicine in St. Louis, Icahn School of Medicine at Mount Sinai in New York City, and Scripps Research in La Jolla, Calif.

Textured breast implants have been linked to a rare and sometimes fatal cancer. Terence M. Myckatyn, MD, who wrote about the issue in a commentary published Oct. 23 in JAMA Surgery, answers questions about the implants.

New research in mice from the School of Medicine suggests obesity may increase arthritis risk not only in obese people but in their children and grandchildren, too.

School of Medicine researchers have demonstrated in a new study that both killer and helper T cells are needed for tumors to be rejected during cancer immunotherapy.

A new School of Medicine study indicates that people with dementia — whose parents also had dementia — develop symptoms an average of six years earlier than their parents.